Newswise — New York, NY (May 11, 2017)—New lung “organoids”—tiny 3-D structures that mimic features of a full-sized lung—have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids to generate models of human lung diseases in a lab dish, which could be used to advance our understanding of a variety of respiratory diseases.
A paper detailing the discovery was published in the April 24 online issue of Nature Cell Biology. Organoids are 3-D structures containing multiple cell types that look and function like a full-sized organ. By reproducing an organ in a dish, researchers hope to develop better models of human diseases, and find new ways of testing drugs and regenerating damaged tissue.
“Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases,” said Hans-Willem Snoeck, PhD, professor of medicine (in Microbiology & Immunology) at CUMC and lead investigator of the study. “But we have been tested by our limited ability to create organoids that can replicate key features of human disease.”
The lung organoids created in Dr. Snoeck’s lab are the first to include branching airway and alveolar structures, similar to human lungs.
To demonstrate their functionality, the researchers showed that the organoids reacted in much the same way as a real lung does when infected with respiratory syncytial virus (RSV). Additional experiments revealed that the organoids also responded as a human lung would when carrying a gene mutation linked to pulmonary fibrosis.
RSV is a major cause of lower respiratory tract infection in infants and has no vaccine or effective antiviral therapy. Idiopathic pulmonary fibrosis, a condition that causes scarring in the lungs, causes 30,000 to 40,000 deaths in the U.S. each year. A lung transplant is the only cure for this condition.
“Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases,” Dr. Snoeck says.
The paper is titled, “A three-dimensional model of human lung development and disease from pluripotent stem cells.” Additional authors (also from Columbia University Medical Center) are Ya-Wen Chen, Sarah Xuelian Huang, Ana Luisa Rodrigues Toste de Carvalho, Siu-Hong Ho, Mohammad Naimul Islam, Jahar Bhattacharya, Laura M. Palermo, Matteo Porotto, and Anne Moscona.
The authors declare no financial or other conflicts of interests.
This work was supported by the National Institutes of Health (grants HL120046-01, 1U01HL134760-01, RO1 AI031971, and RO1 AI114736), as well as a sponsored research agreement from Northern Biologics Inc. and funding from the Thomas R Kully IPF Research Fund.
Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. The campus that Columbia University Medical Center shares with its hospital partner, NewYork-Presbyterian, is now called the Columbia University Irving Medical Center. For more information, visit cumc.columbia.edu or columbiadoctors.org.
MEDIA CONTACTRegister for reporter access to contact details
Nature Cell Biology